Having launched as the CAR-T Summit, in 2016 the evolving CAR-TCR Summit will return to Boston as the only end to end conference dedicated to successfully developing the next generation CAR-T & TCR cell immunotherapies to market.
This Summit will bring together 60+ world-class speakers and over 400 cell therapy experts to drill down into the very latest case studies and capitalize on the promise of transformative CAR-T and TCR therapies. Access never seen before clinical data and exclusively network with scientific and business leaders from large pharma, biotech and academia.
Learn from the pioneers and expand your commercial network at the only senior level summit solely dedicated to the development and manufacture of next generation CAR-T & TCR cell therapies.
“I can’t wait to see the emerging data at this summit, especially clinical and manufacturing, coming from all the CAR-T programs. The chance to share ideas with other CAR-T cell therapy leaders is really exciting.” - David Lebwohl, SVP & Executive Global Program Head, Novartis